Therapeutic Potential of Curcumin in Treatment of Pancreatic Cancer: Current Status and Future Perspectives.

about

Targeting RAS signaling pathway as a potential therapeutic target in the treatment of colorectal cancer.Genetic variation in the DNA repair pathway as a potential determinant of response to platinum-based chemotherapy in breast cancer.Curcumin for the treatment of tumor-stage mycosis fungoides.

P2860

Q39163561-66A32BC4-D42E-4408-A97D-2AF2B6CD925C Q39428059-25795433-E48A-459F-ABFF-285885A0645A Q48323424-72411B0C-E89E-4DA5-82BE-3A699FF769F3

P2860

Therapeutic Potential of Curcumin in Treatment of Pancreatic Cancer: Current Status and Future Perspectives.

Item

http://www.wikidata.org/entity/Q38768150

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Therapeutic Potential of Curcu ...... tatus and Future Perspectives.

@en

type

Item

label

Therapeutic Potential of Curcu ...... tatus and Future Perspectives.

@en

prefLabel

Therapeutic Potential of Curcu ...... tatus and Future Perspectives.

@en

P1476

Therapeutic Potential of Curcu ...... tatus and Future Perspectives.

@en

P2093

Elham Mohammadzadeh

http://www.w3.org/2001/XMLSchema#string

Hasan Fayazbakhsh

http://www.w3.org/2001/XMLSchema#string

Majid Khazaei

http://www.w3.org/2001/XMLSchema#string

Mina Hosseini

http://www.w3.org/2001/XMLSchema#string

Mina Maftouh

http://www.w3.org/2001/XMLSchema#string

Seyed Mahdi Hassanian

http://www.w3.org/2001/XMLSchema#string

Soodabeh ShahidSales

http://www.w3.org/2001/XMLSchema#string

P2860

Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF

Bioavailability of curcumin: problems and promises

[DLys(6)]-luteinizing hormone releasing hormone-curcumin conjugate inhibits pancreatic cancer cell growth in vitro and in vivo.

Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation.

Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia.

Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.

Targeted nanogel conjugate for improved stability and cellular permeability of curcumin: synthesis, pharmacokinetics, and tumor growth inhibition.

Curcumin and cancer: barriers to obtaining a health claim.

Curcumin therapy in inflammatory bowel disease: a pilot study.

Multiple biological activities of curcumin: a short review.

P304

1634-1638

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCB.25897

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

Amir Avan

P577

2017-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28106283

http://www.w3.org/2001/XMLSchema#string

P921

curcumin

Therapeutic Potential of Curcumin in Treatment of Pancreatic Cancer: Current Status and Future Perspectives.

about

P2860

P2860

Therapeutic Potential of Curcumin in Treatment of Pancreatic Cancer: Current Status and Future Perspectives.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921